The examination of the effect of L/N type calcium channel blocker for L-FABP in hypertensive patients with coronary arteries disease.
Not Applicable
- Conditions
- Hypertensive patients with coronary arteries disease.
- Registration Number
- JPRN-UMIN000004679
- Lead Sponsor
- Yokohama Sakae Kyosai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1)Pregnancy or a patient with the possibility 2)History of hypersensitivity to CCBs 3)Malignant hypertension 4)Patients who are inadequate to enter this study due to the other reasons by physician's judgments.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in urinary L-FABP
- Secondary Outcome Measures
Name Time Method Incidence of CIN(A increase at least 0.5mg/dL or a relative increase of at least 25% from baseline value) Blood pressure, heart rate, BUN, Cr(estimated GFR), proteinuria